(PharmaNewsWire.Com, August 29, 2017 ) Due to the global demand for the treatment of stomach ulcers, the use of ranitidine, an over-the-counter and a prescription medication which is used to treat conditions of the stomach, esophagus, and intestines have grown expressively. Recently, a new study on the ranitidine market has been broadcasted to the vast repository of Market Research Hub (MRH), with the title of “Global Ranitidine Market Outlook 2017-2022”. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both volumes and revenue. Through the y-o-y historical analysis, the report aims to provide information on expected market size until the end of 2022.
At first, this report comprises an executive summary along with a market portrait providing overall information of various segments and sub-segments considered in the scope of the study. Moreover, the study has been extensively analyzed based on the market-related factors such as increasing rate of heartburn and stomach ulcers incidences worldwide, technological advancement, and growing number of use of ranitidine treatments in various geographies. Major regions highlighted in the study are North America, Asia Pacific and Europe. The market size and forecast for each of these regions in terms of US$ million for each segment has been provided for the period from 2017 to 2025.
Ranitidine is useful in healing of stomach ulcers and reducing ulcer pain and has been effective in preventing ulcer recurrence when given in low doses for prolonged period of time. Ranitidine belongs to a group of drugs called H2 blockers. It works by decreasing the amount of acid produced in the stomach. When the stomach produces too much acid, the condition is known as Zollinger-Ellison syndrome. This medication comes in regular tablet, effervescent tablet, capsule, and syrup forms. It is also used along with other drugs in treating skin conditions such as hives.
The market overview section of the report explores the market dynamics such as drivers and restraints that currently have a strong impact on the brain tumor diagnosis and treatments market and could influence the market in the near future. Additionally, the report includes the study of opportunities available in the ranitidine market on a global level. Moreover, the concluding section of the report provides information about the profiles of major players in the market considering various attributes such as company overview, financial overview, SWOT analysis, key business strategies, recent developments and product portfolio. The following section also provides a clear insight into the market share analysis of key industry players. At present, key vendors operating in this market include Saraca Laboratories, Neuland Laboratories, Orchev Pharma, Hansitong, SMS Pharmaceuticals, Homesun, Strides Arcolab, Qingyang Yaoye, Uquifa, Zenji, Haili and BSLC.
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
